|
HY-109066-10mg
|
MedChemexpress LLC
|
Olinciguat [CAS 1628732-62-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-109066-100mg
|
MedChemexpress LLC
|
Olinciguat [CAS 1628732-62-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-109066-5mg
|
MedChemexpress LLC
|
Olinciguat [CAS 1628732-62-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-109066-50mg
|
MedChemexpress LLC
|
Olinciguat [CAS 1628732-62-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-109066-1mL
|
MedChemexpress LLC
|
Olinciguat [CAS 1628732-62-6] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-B1486-10mg
|
MedChemexpress LLC
|
Oxprenolol (hydrochloride) [CAS 6452-73-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-B1486-100mg
|
MedChemexpress LLC
|
Oxprenolol (hydrochloride) [CAS 6452-73-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-B1486-25mg
|
MedChemexpress LLC
|
Oxprenolol (hydrochloride) [CAS 6452-73-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-B1486-5mg
|
MedChemexpress LLC
|
Oxprenolol (hydrochloride) [CAS 6452-73-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-B1486-50mg
|
MedChemexpress LLC
|
Oxprenolol (hydrochloride) [CAS 6452-73-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-B1486-1mL
|
MedChemexpress LLC
|
Oxprenolol (hydrochloride) [CAS 6452-73-9] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-B1486S-1mg
|
MedChemexpress LLC
|
Oxprenolol-d7 (hydrochloride) [CAS 1189649-47-5]
|
|
|
|
|
HY-B1486AS-1mg
|
MedChemexpress LLC
|
Oxprenolol-d7 [CAS 1189805-10-4]
|
|
|
|
|
HY-123812-1mg
|
MedChemexpress LLC
|
PF-03654764 [CAS 935840-35-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0817-100mg
|
MedChemexpress LLC
|
Pyridaben [CAS 96489-71-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0817S-1mg
|
MedChemexpress LLC
|
Pyridaben-d13 [CAS 2468638-05-1]
|
|
|
|
|
HY-10037-10mg
|
MedChemexpress LLC
|
Quiflapon [CAS 136668-42-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-10037-100mg
|
MedChemexpress LLC
|
Quiflapon [CAS 136668-42-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-10037-5mg
|
MedChemexpress LLC
|
Quiflapon [CAS 136668-42-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-10037-50mg
|
MedChemexpress LLC
|
Quiflapon [CAS 136668-42-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-10037-1mL
|
MedChemexpress LLC
|
Quiflapon [CAS 136668-42-3] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-107410-10mg
|
MedChemexpress LLC
|
SC-26196 [CAS 218136-59-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-107410-5mg
|
MedChemexpress LLC
|
SC-26196 [CAS 218136-59-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-107410-50mg
|
MedChemexpress LLC
|
SC-26196 [CAS 218136-59-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-107410-1mL
|
MedChemexpress LLC
|
SC-26196 [CAS 218136-59-5] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
